The Vaccine Handbook for PDA
A Practical Guide for Clinicians
Published on 1. September 2004
Software
CD-ROM
300 pages
978-0-7817-4299-3 (ISBN)
Description
This convenient PDA reference offers practical, up-to-date guidelines on proper use of vaccines and helps clinicians answer the many questions asked by patients and parents. Users can quickly get detailed information on all vaccines currently recommended for infants and children, travelers, and individuals in special circumstances. Coverage of each vaccine includes the disease and its epidemiology, the vaccine's efficacy and safety, and the practical questions most frequently asked. Clinicians will find answers to specific parental concerns and guidelines on problems such as allergies, breastfeeding, dosing intervals and missed vaccines, and immunocompromised individuals. It is for platform: Palm OS, Windows CE, and Pocket PC handheld devices.
This convenient PDA reference offers practical, up-to-date guidelines on proper use of vaccines and helps clinicians answer the many questions asked by patients and parents. Users can quickly get detailed information on all vaccines currently recommended for infants and children, travelers, and individuals in special circumstances. Coverage of each vaccine includes the disease and its epidemiology, the vaccine's efficacy and safety, and the practical questions most frequently asked. Clinicians will find answers to specific parental concerns and guidelines on problems such as allergies, breastfeeding, dosing intervals and missed vaccines, and immunocompromised individuals. It is for platform: Palm OS, Windows CE, and Pocket PC handheld devices.
This convenient PDA reference offers practical, up-to-date guidelines on proper use of vaccines and helps clinicians answer the many questions asked by patients and parents. Users can quickly get detailed information on all vaccines currently recommended for infants and children, travelers, and individuals in special circumstances. Coverage of each vaccine includes the disease and its epidemiology, the vaccine's efficacy and safety, and the practical questions most frequently asked. Clinicians will find answers to specific parental concerns and guidelines on problems such as allergies, breastfeeding, dosing intervals and missed vaccines, and immunocompromised individuals. It is for platform: Palm OS, Windows CE, and Pocket PC handheld devices.
More details
Content
CHAPTER I: INTRODUCTION/PREFACE; CHAPTER II: GENERAL CONSIDERATIONS; 1. Background and General Rules; 2. Healthy People 2010 Objectives; 3. Standards and Regulations; 4. The Business of Vaccines in Practice; 5. Practical Issues; 6. Contraindications and Precautions; 7. Vaccine Advocacy; 8. Recommended Childhood Immunization Schedule; 9. Recommended Adult Immunization Schedule; 10. Catch-up Schedules; 11. Vaccine Shortages; CHAPTER III: UNIVERSAL VACCINES FOR CHILDREN AND DOLESCENTS; 12. Diphtheria-Tetanus-accellular Pertussis (DTaP) (Form A); 13. Haemophilus Influenzae Type B Polysaccharide Conjugate (Hib) (Form A); 14. Hepatitis B (Form A); 15. Inactivated Poliovirus (IPV) (Form A); 16. Measles-Mumps-Rubella (MMR) (Form A); 17. Pneumococcal Polysaccharide Conjugate (PCV) (Form A); 18. Varicella; CHAPTER IV NEWER COMBINATION VACCINES; 19. DTaP-Hib (Form A); 20. Hepatitis B-Hib (Form A); 21. Hepatitis B-Hepatitis A (Form A); CHAPTER V: VACCINES FOR ADULTS AND SELECTED CHILDREN; 22. Influenza (Form A); 23. Pneumococcal Polysaccharide (Form A); 24. Diphtheria-Tetanus (dT) (Form A); CHAPTER VI: VACCINES FOR SPECIALIZED USE; 25. Adenovirus (Form A); 26. Bacille Calmette-Gu?rin (BCG) (Form A); 27. Cholera (Form A); 28. Hepatitis A (Form A); 29. Japanese Encephalitis Virus (Form A); 30. Lyme (Form A); 31. Meningococcal Polysaccharide (Form A); 32. Rabies (Form A); 33. Typhoid (Form A); 34. Yellow Fever (Form A); CHAPTER VII: VACCINES AND BIOTERRORISM; 35. General Considerations; 36. Classification of Agents for Bioterrorism; 37. General Strategies for Responding to Terrorism with Vaccination; 38. Specific Vaccines; CHAPTER VIII: VACCINES IN DEVELOPMENT FOR GENERAL USE; 39. Institute of Medicine Report (Form B); 40. Combinations (Form B); 41. Cytomegalovirus (Form B); 42. Epstein-Barr Virus (Form B); 43. Herpes Simplex Virus (Form B); 44. Human Immunodeficiency Virus (Form B); 45. Human Papilloma Virus (Form B); 46. Live Cold-Adapted Influenza (Form B); 47. Meningococcal Polysaccharide Conjugate (Form B); 48. Increased Valency Pneumococcal Polysaccharide Conjugates (Form B); 49. Parainfluenza Virus (Form B); 50. Respiratory Syncytial Virus (Form B); 51. Rotavirus (Form B); CHAPTER IX:PASSIVE IMMUNIZATION; 52. Cytomegalovirus Immune Globulin Intravenous (CMV-IGIV) (Form A); 53. Hepatitis B Immune Globulin (HBIG) (Form A); 54. Immune Globulin (IG) (Form A); 55. Palivizumab (humanized RSV monoclonal antibody) (Form A); 56. Rabies Immune Globulin (RIG) (Form A); 57. Respiratory Syncytial Virus Immune Globulin Intravenous (RSV-IGIV) (Form A); 58. Tetanus Immune Globulin (TIG) (Form A); 59. Varicella Zoster Immune Globulin (VZIG) (Form A); 60. Antitoxins (Form A); CHAPTER X: VACCINATION IN SPECIAL CIRCUMSTANCES; 61. Congenital Immunodeficiencies; 62. Human Immunodeficiency Virus Infection; 63. Immunosuppressive Chemotherapy; 64. Bone Marrow